Stifel
http://www.stifel.com
Stifel Financial Corp. is a full-service regional brokerage and investment banking firm, established in 1890 and based in St. Louis, Missouri.
The Company provides securities brokerage, investment banking, trading, investment advisory, and related financial services through its wholly owned subsidiaries, primarily Stifel, Nicolaus & Company, Incorporated, to individual investors, professional money managers, businesses, and municipalities.
-
-
-
-
-
-
-
Xenon Pharmaceuticals Announces Proposed Public Offering
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Xenon Pharmaceuticals (XENE)
-
-
-
-
-
-
-
Xenon Pharmaceuticals Announces Pricing of Upsized $300.0 Million Public Offering
-
-
-
-
-
-
-
Xenon Pharmaceuticals (XENE) Prices 7.87M Share Offering at $30.50/sh
-
-
-
-
-
-
-
Xenon Pharmaceuticals to Present at Stifel 2022 CNS Days
-
-
-
-
-
-
-
Xenon Pharmaceuticals Announces Closing of $345 Million Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
-
-
-
-
-
-
Xenon Pharmaceuticals (XENE) PT Raised to $44 at Stifel
-
43,004 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

